Paradigm4 - About the company
Paradigm4 is a series A company based in Waltham (United States), founded in 2009. It operates as a Clinical data management and analytic tools. Paradigm4 has raised an undisclosed amount in funding. The company has 1117 active competitors, including 168 funded and 83 that have exited. Its top competitors include companies like Benchling, Helix and Kyruus Health.
Company Details
Clinical data management and analytic tools. It offers an analytics platform that enables scientists, data scientists, bio-informaticians, analysts to solve their analytical problems in industries ranging from pharmaceutical, biotech, and healthcare to insurance and telematics, energy research, and finance. In life sciences, the company's next-generation tools can be used for precision medicine programs, to accelerate bioinformatics research, and others.
- Website
- paradigm4.com
- Registered Address
- Waltham, Massachusetts
Key Metrics
Founded Year
2009
Location
Waltham, United States
Stage
Series A
Latest Funding Round
Investors
Ranked
178th among 1117 active competitors
Employee Count
28 as on May 31, 2026
Similar Companies
Legal entities associated with Paradigm4
Paradigm4 is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
PARADIGM4 INC. CIN: 271448271 , United States, Active | Dec 31, 1999 | - | 21 (As on Dec 31, 2024) | - |
Sign up to download Paradigm4's company profile
Paradigm4's funding and investors
Paradigm4 has raised funding over 1 round. Its latest funding round was a Series A round on Nov 30, 2015 for $*****. 3 investors participated in its latest round. Paradigm4 has 6 institutional investors.
Here is the list of recent funding rounds of Paradigm4:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Nov 30, 2015 | 3358954 | Series A | 2788840 | 7157162 | 6005339 | 7260375 |
View details of Paradigm4's funding rounds and investors
Paradigm4's founders and board of directors
Founder? Claim ProfileParadigm4's employee count trend
Paradigm4 has 28 employees as of May 26. Here is Paradigm4's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Paradigm4's Competitors and alternates
Top competitors of Paradigm4 include Benchling, Helix and Kyruus Health. Here is the list of Top 10 competitors of Paradigm4, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Benchling 2012, San Francisco (United States), Series F | Provider of a cloud-based bioinformatics platform for biotech research | $412M | 73/100 | |
2nd | Helix 2015, San Francisco (United States), Series E | Provider of a genomic database for clinical research | $435M | 71/100 | |
3rd | Kyruus Health 2010, Boston (United States), Acquired | Provider of software solutions for clinical decision making | $196M | 68/100 | |
4th | Truveta 2020, Seattle (United States), Series C | Provider of healthcare data platform for learning services | $515M | 65/100 | |
5th | nference 2013, Cambridge (United States), Series C | Provider of an AI platform for clinical data analysis and insights | $134M | 64/100 | |
6th | Carta Healthcare 2017, San Mateo (United States), Series B | Provider of an AI platform for clinical data management solutions | $80.5M | 64/100 | |
7th | Congenica 2013, Cambridge (United Kingdom), Acquired | Developer of software for clinical genomic interpretation and variant analysis | $81.9M | 62/100 | |
8th | OM1 2015, Cambridge (United States), Series C | Platform that enables providers to manage CMS CJR bundle for value-based care | $171M | 62/100 | |
9th | Abacus Insights 2017, New York City (United States), Series C | Provider of data management solutions | $94.9M | 62/100 | |
10th | Sophia Genetics 2011, Rolle (Switzerland), Public | Provider of artificial intelligence software for analyzing complex medical data | $249M | 62/100 | |
178th | Paradigm4 2009, Waltham (United States), Series A | Clinical data management and analytic tools | - | 33/100 |
Looking for more details on Paradigm4's competitors? Click here to see the top ones
Paradigm4's Investments and acquisitions
Paradigm4 has made no investments or acquisitions yet.
Reports related to Paradigm4
Here is the latest report on Paradigm4's sector:
News related to Paradigm4
•
•
Adoption Momentum For Paradigm4’s UK Biobank PlatformBusiness Wire•Dec 11, 2018•Paradigm4, UK Biobank
•
•
Golden Seeds Invests in Paradigm4 - Paradigm4Paradigm4•Nov 30, 2015•Paradigm4, Golden Seeds, Sigma Partners, Kepha Partners
•
Are you a Founder ?
FAQs about Paradigm4
Explore our recently published companies
- Otzarreta Think And Make - Gipuzkoa based, 1970 founded, Unfunded company
- Accelerate360Canada - Burlington based, 1969 founded, Acquired company
- Mabsolutions - Darmstadt based, Funding Raised company
- Synscribe - Singapore based, 2025 founded, Unfunded company
- Native Ecology - Denver based, 2000 founded, Funding Raised company
- MackyClyde SEO - Bangsar based, 2020 founded, Unfunded company